BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 18559969)

  • 41. Initial response to glucocorticoids.
    Mathew BS; Carson KA; Grossman SA
    Cancer; 2006 Jan; 106(2):383-7. PubMed ID: 16342251
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Trends in survival from primary central nervous system lymphoma, 1975-1999: a population-based analysis.
    Panageas KS; Elkin EB; DeAngelis LM; Ben-Porat L; Abrey LE
    Cancer; 2005 Dec; 104(11):2466-72. PubMed ID: 16240449
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Combined-modality therapy for primary central nervous system lymphoma: long-term data from a Phase II multicenter study (Trans-Tasman Radiation Oncology Group).
    O'Brien PC; Roos DE; Pratt G; Liew KH; Barton MB; Poulsen MG; Olver IN; Trotter GE;
    Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):408-13. PubMed ID: 16198065
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Results of radiation monotherapy for primary central nervous system lymphoma in the 1990s.
    Shibamoto Y; Ogino H; Hasegawa M; Suzuki K; Nishio M; Fujii T; Kato E; Ishihara S; Sougawa M; Kenjo M; Kawamura T; Hayabuchi N
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):809-13. PubMed ID: 15936564
    [TBL] [Abstract][Full Text] [Related]  

  • 45. NOA-03 trial of high-dose methotrexate in primary central nervous system lymphoma: final report.
    Herrlinger U; Küker W; Uhl M; Blaicher HP; Karnath HO; Kanz L; Bamberg M; Weller M;
    Ann Neurol; 2005 Jun; 57(6):843-7. PubMed ID: 15929034
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The treatment of primary central nervous system lymphoma in 122 immunocompetent patients: a population-based study of successively treated cohorts from the British Colombia Cancer Agency.
    Shenkier TN; Voss N; Chhanabhai M; Fairey R; Gascoyne RD; Hoskins P; Klasa R; Morris J; O'Reilly SE; Pickles T; Sehn L; Connors JM
    Cancer; 2005 Mar; 103(5):1008-17. PubMed ID: 15651059
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Primary non-Hodgkin's lymphoma of the CNS treated with CHOD/BVAM or BVAM chemotherapy before radiotherapy: long-term survival and prognostic factors.
    Bessell EM; Graus F; Lopez-Guillermo A; Lewis SA; Villa S; Verger E; Petit J
    Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):501-8. PubMed ID: 15145169
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Primary central nervous system lymphoma in Japan 1995-1999: changes from the preceding 10 years.
    Shibamoto Y; Tsuchida E; Seki K; Oya N; Hasegawa M; Toda Y; Takemoto M; Sumi M; Hiratsuka J; Oguchi M; Hosono M; Yasuda S; Sougawa M; Kakutoh Y; Hayabuchi N
    J Cancer Res Clin Oncol; 2004 Jun; 130(6):351-6. PubMed ID: 15034788
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Primary central nervous system lymphoma: a curable brain tumor.
    DeAngelis LM
    J Clin Oncol; 2003 Dec; 21(24):4471-3. PubMed ID: 14597745
    [No Abstract]   [Full Text] [Related]  

  • 50. High-dose methotrexate-based chemotherapy followed by consolidating radiotherapy in non-AIDS-related primary central nervous system lymphoma: European Organization for Research and Treatment of Cancer Lymphoma Group Phase II Trial 20962.
    Poortmans PM; Kluin-Nelemans HC; Haaxma-Reiche H; Van't Veer M; Hansen M; Soubeyran P; Taphoorn M; Thomas J; Van den Bent M; Fickers M; Van Imhoff G; Rozewicz C; Teodorovic I; van Glabbeke M;
    J Clin Oncol; 2003 Dec; 21(24):4483-8. PubMed ID: 14597741
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prognostic scoring system for primary CNS lymphomas: the International Extranodal Lymphoma Study Group experience.
    Ferreri AJ; Blay JY; Reni M; Pasini F; Spina M; Ambrosetti A; Calderoni A; Rossi A; Vavassori V; Conconi A; Devizzi L; Berger F; Ponzoni M; Borisch B; Tinguely M; Cerati M; Milani M; Orvieto E; Sanchez J; Chevreau C; Dell'Oro S; Zucca E; Cavalli F
    J Clin Oncol; 2003 Jan; 21(2):266-72. PubMed ID: 12525518
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Is whole-brain irradiation necessary for primary central nervous system lymphoma? Patterns of recurrence after partial-brain irradiation.
    Shibamoto Y; Hayabuchi N; Hiratsuka J; Tokumaru S; Shirato H; Sougawa M; Oya N; Uematsu Y; Hiraoka M
    Cancer; 2003 Jan; 97(1):128-33. PubMed ID: 12491514
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Combination chemotherapy and radiotherapy for primary central nervous system lymphoma: Radiation Therapy Oncology Group Study 93-10.
    DeAngelis LM; Seiferheld W; Schold SC; Fisher B; Schultz CJ;
    J Clin Oncol; 2002 Dec; 20(24):4643-8. PubMed ID: 12488408
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Importance of radiotherapy in the outcome of patients with primary CNS lymphoma: an analysis of the CHOD/BVAM regimen followed by two different radiotherapy treatments.
    Bessell EM; López-Guillermo A; Villá S; Verger E; Nomdedeu B; Petit J; Byrne P; Montserrat E; Graus F
    J Clin Oncol; 2002 Jan; 20(1):231-6. PubMed ID: 11773174
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical relevance of consolidation radiotherapy and other main therapeutic issues in primary central nervous system lymphomas treated with upfront high-dose methotrexate.
    Reni M; Ferreri AJ; Guha-Thakurta N; Blay JY; Dell'Oro S; Biron P; Hochberg FH
    Int J Radiat Oncol Biol Phys; 2001 Oct; 51(2):419-25. PubMed ID: 11567816
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Therapeutic management of primary central nervous system lymphoma: lessons from prospective trials.
    Ferreri AJ; Reni M; Villa E
    Ann Oncol; 2000 Aug; 11(8):927-37. PubMed ID: 11038028
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A medical research council randomized trial in patients with primary cerebral non-Hodgkin lymphoma: cerebral radiotherapy with and without cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy.
    Mead GM; Bleehen NM; Gregor A; Bullimore J; Shirley D; Rampling RP; Trevor J; Glaser MG; Lantos P; Ironside JW; Moss TH; Brada M; Whaley JB; Stenning SP
    Cancer; 2000 Sep; 89(6):1359-70. PubMed ID: 11002232
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Treatment for primary CNS lymphoma: the next step.
    Abrey LE; Yahalom J; DeAngelis LM
    J Clin Oncol; 2000 Sep; 18(17):3144-50. PubMed ID: 10963643
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Primary central nervous system lymphoma in Japan: a nationwide survey.
    Hayabuchi N; Shibamoto Y; Onizuka Y
    Int J Radiat Oncol Biol Phys; 1999 May; 44(2):265-72. PubMed ID: 10760418
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Radiotherapy in the treatment of primary central nervous system lymphoma (PCNSL).
    Nelson DF
    J Neurooncol; 1999 Jul; 43(3):241-7. PubMed ID: 10563430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.